Skip to main content
Caplight Logo









advanceCOR

advanceCOR

Private
PlaneggHealthcare & Life Scienceshttps://advancecor.de/

Last Round

VC Round

Jun 2, 2020

Total Funding Raised

$8.52M

Company Overview

advanceCOR is a biotechnology company that develops innovative drugs and diagnostics for the personalized treatment of cardiovascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologyprotein therapeuticscardiovascular diseaseatherothrombosiscompanion diagnosticsdrug discoverygood laboratory practiceGLPpersonalized medicinebiotech startupfusion proteinclinical developmentbiomedical researchcyclic peptidesdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

advanceCOR Comparables

Compare advanceCOR with similar companies based on industry and business-model similarity.

advanceCOR comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lumosa Therapeutics Co. Ltd.
64%
Basking Biosciences
63%
EMFRET Analytics GmbH & Co. KG
62%

advanceCOR Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 2, 2020
VC RoundMay 21, 2018
VC RoundAug 24, 2015
Series AApr 10, 2013

advanceCOR Investors

Notable investors and investment history

advanceCOR investors
InvestorRounds
First Capital Partner GmbHVC Round
MIG AGSeries A, VC Round
Bayern KapitalVC Round, Series A
KfW Development BankVC Round, Series A
High-Tech GründerfondsVC Round, Series A
BioM AG Munich BioTech DevelopmentVC Round, Series A
MIG FondsVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 24, 2015

    $2.5M round led by MIG AG.

  • Apr 10, 2013

    $8.5M round led by Bayern Kapital and High-Tech Gründerfonds.

advanceCOR Filings

Explore SEC and related filing metadata, where available.

advanceCOR filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about advanceCOR's valuation, stock price, and market status.

Is advanceCOR a public or private company?

advanceCOR is a private company.

What is the current stock price of advanceCOR?

advanceCOR is a private company with no public stock price. Caplight tracks advanceCOR's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is advanceCOR worth (valuation)?

Valuation information for advanceCOR is not publicly available.

Can I buy advanceCOR stock?

advanceCOR shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was advanceCOR's last funding round?

advanceCOR's most recent funding round was VC Round on June 2, 2020.

Who are the main investors in advanceCOR?

Key investors in advanceCOR include MIG AG, MIG Fonds.

Will advanceCOR IPO soon?

No public IPO plans have been announced for advanceCOR.

How can I track advanceCOR secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor advanceCOR's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPlanegg
Employee Range5
Year Founded2012
Last FundingJun 2, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?